328 related articles for article (PubMed ID: 3121928)
1. Steroids and neuroendocrine function in anorexia nervosa.
Casanueva FF; Borras CG; Burguera B; Muruais C; Fernández M; Devesa J
J Steroid Biochem; 1987; 27(1-3):635-40. PubMed ID: 3121928
[TBL] [Abstract][Full Text] [Related]
2. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hypothalamic-pituitary function in a combination of tests with four hypothalamic releasing hormones and L-dopa in normal subjects and in patients with hypothalamic and/or pituitary disorders.
Bando H; Yamasaki R; Saito S
Endocrinol Jpn; 1989 Oct; 36(5):705-20. PubMed ID: 2559840
[TBL] [Abstract][Full Text] [Related]
4. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
5. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
[TBL] [Abstract][Full Text] [Related]
6. Endogenous opioid blockade and gonadotropin secretion: role of pulsatile luteinizing hormone-releasing hormone administration in anorexia nervosa and weight loss amenorrhea.
Giusti M; Torre R; Traverso L; Cavagnaro P; Attanasio R; Giordano G
Fertil Steril; 1988 May; 49(5):797-801. PubMed ID: 3129313
[TBL] [Abstract][Full Text] [Related]
7. Some aspects of hypothalamic-pituitary function in patients with anorexia nervosa.
Travaglini P; Beck-Peccoz P; Ferrari C; Ambrosi B; Paracchi A; Severgnini A; Spada A; Faglia G
Acta Endocrinol (Copenh); 1976 Feb; 81(2):252-62. PubMed ID: 813472
[TBL] [Abstract][Full Text] [Related]
8. [The role of the endogenous opioid system in the pathogenesis of polycystic ovary syndrome: the altered neuroendocrine regulation of GnRH-LH is corrected after clomiphene therapy].
Barletta C; Vagiri D; Scavo D
Minerva Endocrinol; 1992; 17(3):107-19. PubMed ID: 1298870
[TBL] [Abstract][Full Text] [Related]
9. Influence of naloxone infusion on prolactin and growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
De Marinis L; Mancini A; D'Amico C; Zuppi P; Tofani A; Della Casa S; Saporosi A; Sambo P; Fiumara C; Calabró F
Psychoneuroendocrinology; 1991; 16(6):499-504. PubMed ID: 1811245
[TBL] [Abstract][Full Text] [Related]
10. Opioid dysregulation in anorexia nervosa: naloxone effects on preprandial and postprandial growth hormone response to growth hormone-releasing hormone.
De Marinis L; Mancini A; Zuppi P; Fiumara C; Fabrizi ML; Sammartano L; Conte G; Valle D; Daini S; Ferro FM
Metabolism; 1994 Feb; 43(2):140-3. PubMed ID: 8121292
[TBL] [Abstract][Full Text] [Related]
11. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
[TBL] [Abstract][Full Text] [Related]
12. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic-pituitary-gonadal function in anorexia nervosa and bulimia.
Devlin MJ; Walsh BT; Katz JL; Roose SP; Linkie DM; Wright L; Vande Wiele R; Glassman AH
Psychiatry Res; 1989 Apr; 28(1):11-24. PubMed ID: 2500676
[TBL] [Abstract][Full Text] [Related]
14. Amenorrhea in anorexia nervosa. Neuroendocrine control of hypothalamic dysfunction.
Golden NH; Shenker IR
Int J Eat Disord; 1994 Jul; 16(1):53-60. PubMed ID: 7920581
[TBL] [Abstract][Full Text] [Related]
15. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Berga SL; Yen SS
Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.
Berga SL; Mortola JF; Girton L; Suh B; Laughlin G; Pham P; Yen SS
J Clin Endocrinol Metab; 1989 Feb; 68(2):301-8. PubMed ID: 2493024
[TBL] [Abstract][Full Text] [Related]
17. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients.
Gold PW; Gwirtsman H; Avgerinos PC; Nieman LK; Gallucci WT; Kaye W; Jimerson D; Ebert M; Rittmaster R; Loriaux DL
N Engl J Med; 1986 May; 314(21):1335-42. PubMed ID: 3010109
[TBL] [Abstract][Full Text] [Related]
18. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
19. [Anorexia nervosa: endocrine function during the phases of body weight loss and recovery].
Méndez JP; García E; Salinas JL; Pérez-Palacios G; Ulloa-Aguirre A
Rev Invest Clin; 1989; 41(4):337-44. PubMed ID: 2517152
[TBL] [Abstract][Full Text] [Related]
20. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
